Skip to main content
. 2014 Aug 23;5(20):10198–10205. doi: 10.18632/oncotarget.2548

Table 2: Comparison of the AUC1 and AUC2 scores calculated for 81 intracellular signaling pathways for nine human cancer types basing on the transcriptomic data.

Cancer type AUC1 > 0.7a AUC2 > 0.7b AUC1/2 > 0.7; AUC1 > AUC2c AUC1/2 > 0.7; AUC2 > AUC1d AUC1 > 0.75e AUC2 > 0.75f AUC1/2 > 0.75; AUC1 > AUC2g AUC1/2 > 0.75; AUC2 > AUC1h
Basal cell carcinoma 40 5 40 1 23 0 23 0
Bladder cancer 20 23 15 15 10 9 8 4
Glioblastoma 66 68 66 12 59 5 59 0
Hepatocellular 17 0 17 0 7 0 7 0
Lung adenocarcinoma 32 2 32 1 21 0 21 0
Oral tongue squamous cell carcinoma 5 0 5 0 2 0 2 0
Primary melanoma 25 0 25 0 13 0 13 0
Prostate cancer 28 8 28 5 16 0 16 0
Renal cancer 19 10 19 6 10 0 10 0
a

Number of signaling pathways where AUC1 > 0.7

b

Number of signaling pathways where AUC2 > 0.7

c

Number of signaling pathways where AUC1/2 > 0.7, and AUC1 > AUC2

d

Number of signaling pathways where AUC1/2 > 0.7, and AUC2 > AUC1

e

Number of signaling pathways where AUC1 > 0.75

f

Number of signaling pathways where AUC2 > 0.75

g

Number of signaling pathways where AUC1/2 > 0.75, and AUC1 > AUC2

h

Number of signaling pathways where AUC1/2 > 0.75, and AUC2 > AUC1